CAS 2381089-83-2

Retatrutide, by acting simultaneously on three receptors (GLP-1, GIP, and GCGR), can not only suppress appetite and delay gastric emptying, but also enhance energy expenditure, and is considered a representative of the new generation of weight loss drugs.